At Balcanns, we’re dedicated to producing low-cost, GMP-certified medicinal cannabis to supply the EU and other key markets with premium extracts.
We leverage our Canadian expertise and technology to produce industry-leading medicinal cannabis at our state-of-the-art facilities in North Macedonia.
North Macedonia is a globally competitive, low-cost jurisdiction that is in the process of entering the EU.
The country possesses an ideal climate for cannabis production and a strong history of commercial horticulture.
Combined with cutting edge production and extraction technologies, our goal is to produce and deliver unrivaled premium medical cannabis extracts to countries across Europe and around the world.
We’ve secured the rights to a 22-hectare/54 acre compound located near Prilep, North Macedonia.
We will leverage our Canadian expertise and technology to produce industry-leading medicinal cannabis at our state-of-the-art facilities in North Macedonia.
We supply the rapidly expanding medical cannabis market with premium extracts. Our products are safe, consistent, effective, and reliable.
We have extensive experience in both controlling the environmental parameters in plant production systems and in safety/pharmaceutical systems.
Plant Tissue Culture
Plant tissue culture (micropropagation) is a series of techniques where plant cells are grown under sterile conditions on a nutrient culture medium.
Tissue culture has many advantages over the standard techniques used in the cannabis industry: small footprint, lower chance of disease being transmitted, and it is effective for mass propagation.
The use of plant tissue culture gives Balcanns a significant technological advantage over our competition.
Opportunity in Europe
Europe possesses the largest medical cannabis market in the world
742 Million People
€2.3 Trillion Euro annual healthcare expenditure
€58 Billion in forecasted market value by 2028
Why North Macedonia
North Macedonia is strategically positioned to produce high-end, premium cannabis products at a low cost.
- Potentially entering the EU & NATO
- Low corporate tax rate (10%)
- Favorable legal climate
- Strategic geographic position: Well positioned to supply key European cannabis markets
- Qualified labour force at globally competitive costs
- 10th on World Bank ‘Ease of Doing Business’ List
- Ideal climate for cannabis production
Success to Date
TORONTO, May 9, 2019 /CNW/ – Cannabis Growth Opportunity Corporation (“CGOC“, or the “Company“) (CSE: CGOC), a cannabis-focused investment corporation with both public and private cannabis holdings, is pleased to announce a new investment within its private portfolio in MKK Canada Corporation (“Balcanns“), a burgeoning cannabis supplier in North Macedonia. With the European cannabis market…Read More
Request Investor Deck
Complete the form below to receive our full investors deck to find out more.